BDAFX
Price
$33.67
Change
+$0.54 (+1.63%)
Updated
Jun 11 closing price
Net Assets
510.67M
VIGRX
Price
$263.08
Change
+$4.70 (+1.82%)
Updated
Jun 11 closing price
Net Assets
393.82B
Interact to see
Advertisement

BDAFX vs VIGRX

Header iconBDAFX vs VIGRX Comparison
Open Charts BDAFX vs VIGRXBanner chart's image
BDAFX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
BDAFX vs. VIGRX commentary
Jun 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDAFX is a Hold and VIGRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 394B vs. BDAFX (511M). VIGRX pays higher dividends than BDAFX: VIGRX (0.26) vs BDAFX (0.00). BDAFX was incepted earlier than VIGRX: BDAFX (8 years) vs VIGRX (34 years). BDAFX (1.00) is less costly to investors than VIGRX (0.17). BDAFX is a more actively managed with annual turnover of: 13.00 vs. VIGRX (12.00). VIGRX has a lower initial minimum investment than BDAFX: VIGRX (0) vs BDAFX (2000). VIGRX annual gain was more profitable for investors over the last year : 18.59 vs. BDAFX (12.88). BDAFX return over 5 years is better than : 87.48 vs. VIGRX (81.99).
BDAFXVIGRXBDAFX / VIGRX
Total Expense Ratio0.950.17559%
Annual Report Gross Expense Ratio1.000.17588%
Fund Existence8 years34 years-
Gain YTD0.9142.84632%
Front LoadN/AN/A-
Min. Initial Investment20000-
Min. Initial Investment IRAN/AN/A-
Net Assets511M394B0%
Annual Yield % from dividends0.000.26-
Returns for 1 year12.8818.5969%
Returns for 3 years73.2082.7588%
Returns for 5 years87.4881.99107%
Returns for 10 yearsN/A371.11-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COOT0.670.05
+8.05%
Australian Oilseeds Holdings Limited
NUE260.9010.41
+4.16%
Nucor Corp
OMDA17.730.63
+3.65%
Omada Health Inc
CHH107.413.18
+3.05%
Choice Hotels Intnl
QTTB12.69-0.18
-1.40%
Q32 Bio